Marval Biosciences' Debt Round

Marval Biosciences raised a round of funding on November 02, 2011.

Marval Biosciences is an early stage company, developing contrast agents for use in X-ray and Computed Tomography (CT) Imaging. Marval's lead candidate, NCTX, targets cardiovascular imaging.…

Articles about Marval Biosciences' Debt Round: